approval
saveZEPBOUND (TIRZEPATIDE) — FDA approval
community read0 votes
Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalFeb 25, 2026 · 219d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalJan 20, 2026 · 255d ago
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalJan 20, 2026 · 255d ago
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalJan 7, 2026 · 268d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalJan 7, 2026 · 268d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalDec 19, 2025 · 287d ago
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalSep 25, 2025 · 372d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalSep 25, 2025 · 372d ago
same company · ±60 days · 6
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalDec 18, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalDec 18, 2024
- approvalmirikizumab: OMVOH (MIRIKIZUMAB-MRKZ) — FDA approvalJan 15, 2025
- approvalmirikizumab: OMVOH (MIRIKIZUMAB-MRKZ) — FDA approvalJan 15, 2025
- approvaldulaglutide: TRULICITY (DULAGLUTIDE) — FDA approvalNov 1, 2024
- approvalZEPBOUND: MOUNJARO (TIRZEPATIDE) — FDA approvalNov 1, 2024
comments(0)
5-min edit window · permanent after that